Annex I to Implementing Regulation (EU) 2021/403 is amended as follows:
Chapter 1 is replaced by the following:
EUROPEAN UNION | INTRA
1 | Consignor | | I.2 | IMSOC reference | |
Name | | I.2a | Local reference | |
Address | | I.3 | Central Competent Authority | | QR CODE
Country | ISO country code | I.4 | Local Competent Authority | |
5 | Consignee | | I.6 | Operator conducting assembly operations independently of an establishment
Name | | | Name | Registration No
Address | | | Address |
Country | ISO country code | | Country | ISO country code
7 | Country of origin | ISO country code | I.9 | Country of destination | ISO country code
8 | Region of origin | Code | I.10 | Region of destination | Code
11 | Place of dispatch | | I.12 | Place of destination |
Name | Registration/Approval No | | Name | Registration/Approval No
Address | | | Address |
Country | ISO country code | | Country | ISO country code
13 | Place of loading | I.14 | Date and time of departure
15 | Means of transport | | I.16 | Transporter
☐ Vessel | ☐ Aircraft | | Name | Registration/Authorisation No
Address |
☐ Railway | ☐ Road vehicle | | Country | ISO country code
17 | Accompanying documents
Identification | ☐ Other | | Type | Code
Document | | Country | ISO country code
Commercial document reference |
18 | Transport conditions | ☐ Ambient | ☐ Chilled | ☐ Frozen
19 | Container number/Seal number
Container No | Seal No |
20 | Certified as or for
☐ Further keeping | ☐ Slaughter | ☐ Confined establishment | ☐ Germinal products
☐ Registered equine animal | ☐ Travelling circus/animal act | ☐ Exhibition | ☐ Event or activity near borders
☐ Release into the wild | ☐ Dispatch centre | ☐ Relaying area/purification centre | ☐ Ornamental aquaculture establishment
☐ Further processing | ☐ Organic fertilizers and soil improvers | ☐ Technical use | ☐ Quarantine or similar establishment
☐ Products for human consumption | ☐ Pollination | ☐ Live aquatic animals for human consumption | ☐ Other
21 | ☐ For transit through a third country
Third country | ISO country code
Exit point | BCP code
Entry point | BCP code
22 | ☐ For transit through Member State(s) | I.23 | ☐ For export
Member State | ISO country code | | Third country | ISO country code
Member State | ISO country code | | Exit point | BCP code
Member State | ISO country code | | |
24 | Estimated journey time | I.25 | Journey log | ☐ yes | ☐ no
26 | Total number of packages | I.27 | Total quantity
28 | Total net weight/gross weight (kg) | I.29 | Total space foreseen for the consignment
30 | Description of consignment
CN code | Species | Subspecies/Category | Sex | Identification system | Identification number | Age | Quantity
Type
Region of origin | | Cold store | | Identification mark | Type of packaging | | Net weight
Slaughterhouse | | Treatment type | | Nature of commodity | Number of packages | | Batch No
Date of collection/production | | Manufacturing plant | Approval or registration number of plant/establishment/centre | Test |
EUROPEAN UNION | Certificate model BOV-INTRA-X
Health information | II.a | Certificate reference | II.b | IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
1. The bovine animals (1) of the consignment described in Part I meet the following requirements:
1.1. They are identified as provided for in Article 38 of Commission Delegated Regulation (EU) 2019/2035.
1.2. They, for at least 30 days prior to the date of departure of the consignment, or since birth, if they are younger than 30 days of age:
1.2.1. have been continuously resident in the establishment of origin;
1.2.2. have not been in contact with kept bovine animals of a lower health status or subject to movement restrictions for animal health reasons;
1.2.3. have not been in direct or indirect contact with kept animals that have entered the Union from a third country or territory during the last 30 days prior to the date of departure of the animals.
1.3. They have not shown clinical signs or symptoms of diseases listed for bovine animals during the clinical examination which was carried out, within the last 24 hours prior to the time of departure of the consignment, on … (insert date dd/mm/yyyy).
2. According to official information, the animals described in Part I meet the following health requirements:
2.1. (2) either [They come from establishments or zones not subject to movement restrictions affecting bovine animals and established for reasons of diseases listed for those species or diseases subject to emergency measures relevant for those species, and they have not been in contact with kept animals of a listed species of a lower health status for an adequate period.]
or [They come from establishments or zones subject to movement restrictions affecting bovine animals and established for … (3), but derogations from movement restrictions have been granted, and:
[they comply with the requirements set out in …(4);]]
[and in particular, they are … (5).]]
2.2. They come from establishments free from infection with Brucella abortus, B. melitensis and B. suis without vaccination regarding bovine animals, and:
either [the establishments of origin are situated in a Member State or zone thereof with the status free from infection with Brucella abortus, B. melitensis and B. suis regarding the bovine population;]
and/or [they have been subjected to a test for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on a sample taken during the last 30 days prior to the date of departure, and in the case of post-parturient females taken at least 30 days after parturition;]
and/or [they are less than 12 months old;]
and/or [they are castrated.]
2.3. They come from establishments free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), and:
either [the establishments of origin are situated in a Member State or zone thereof with the status free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis);]
and/or [they have been subjected to a test for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) with one of the diagnostic methods provided for in Part 2 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, during the last 30 days prior to the date of departure of the consignment;]
and/or [they are less than 6 weeks old.]
2.4. They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of departure of the consignment.
2.5. They come from establishments situated in an area of at least 150 km radius around those establishments in which infection with epizootic haemorrhagic disease virus:
either [has not been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment;]
and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX to Delegated Regulation (EU) 2020/688:
either [for at least 60 days prior to the date of departure of the consignment;]]
and/or [for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally disease-free area;]]
and/or [for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the seasonally disease-free area;]]
and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been protected against attacks by vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX to Delegated Regulation (EU) 2020/688:
either [for at least 60 days prior to the date of departure of the consignment;]]
and/or [for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]
and/or [for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors;]]
and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been vaccinated against infection with epizootic haemorrhagic disease virus and the animals are within the immunity period guaranteed in the specifications of the vaccine and:
either [they have been vaccinated at least 60 days prior to the date of departure of the consignment;]]
and/or [they have been vaccinated with an inactivated vaccine and have been subject to a PCR test, with negative results on samples collected at least 14 days after the onset of the immunity set in the specifications of the vaccine;]]
and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]
and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals comply with specific risk-mitigating measures defined by the competent authority of the Member State of destination and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]
and [the requirements laid down in Article 10(1), third subparagraph, of Delegated Regulation (EU) 2020/688 are fulfilled.]
2.6. They come from establishments in which anthrax in ungulates has not been reported during the last 15 days prior to the date of departure of the consignment.
2.7. They come from establishments in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to the date of departure of the consignment, and
either [surra has not been reported in the establishments during the last 2 years prior to the date of their departure.]
or [surra has been reported during the last 2 years prior to the date of departure of the consignment, and following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishments.]
either [II.2.8. They originate from a Member State or a zone thereof free from infection with bluetongue virus (serotypes 1-24), where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of departure of the consignment, and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1-24) in the last 60 days prior to the date of departure of the consignment and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]
and/or [II.2.8. They originate from a Member State or a zone thereof covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they:
either [II.2.8.1. have been kept in a Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24) in accordance with Article 40(3) of Commission Delegated Regulation (EU) 2020/689:
either [II.2.8.1.1. for at least 60 days prior to the date of departure of the consignment;]]
and/or [II.2.8.1.2. for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]
and/or [II.2.8.1.3. for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]]
and/or [II.2.8.2. have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:
either [II.2.8.2.1. for at least 60 days prior to the date of departure of the consignment;]]
and/or [II.2.8.2.2. for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]
and/or [II.2.8.2.3. for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]
and/or [II.2.8.3. have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported in that Member State or zone thereof during the last 2 years prior to the date of departure of the consignment and are within the immunity period guaranteed in the specifications of the vaccine and:
either [II.2.8.3.1. have been vaccinated more than 60 days prior to the date of departure of the consignment;]]
and/or [II.2.8.3.2. have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]
and/or [II.2.8.4. have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1-24 of infection with bluetongue virus reported in that Member State or zone thereof during the last 2 years prior to the date of departure of the consignment, and:
either [II.2.8.4.1. the serological test has been carried out on samples collected at least 60 days prior to the date of departure of the consignment.]]]
and/or [II.2.8.4.2. the serological test has been carried out on samples collected at least 30 days prior to the date of departure of the consignment and the animals have been subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment.]]]
and/or [II.2.8. They originate from a Member State or a zone thereof neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they:
either [II.2.8.1. have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:
either [II.2.8.1.1. for at least 60 days prior to the date of departure of the consignment;]]
and/or [II.2.8.1.2. for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]
and/or [II.2.8.1.3. for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]
and/or [II.2.8.2. have been kept for the last 60 days prior to the date of departure of the consignment in an establishment situated in a Member State or within an area of at least 150 km radius centred on the establishment, where surveillance in compliance with the requirements set out in Part II, Chapter 1, Sections 1 and 2, of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and:
either [II.2.8.2.1. the animals have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment within an area of at least 150 km radius centred on the place where the animals were kept and are within the immunity period guaranteed in the specifications of the vaccine, and:
either [II.2.8.2.1.1. have been vaccinated more than 60 days prior to the date of departure of the consignment;]]]
and/or [II.2.8.2.1.2. have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results on samples collected at least 14 days after the date of onset of the immunity set in the specifications of the vaccine;]]]]
and/or [II.2.8.2.2. the animals have been immunised against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment in an area of at least 150 km radius centred on the place where the animals were kept, and:
either [II.2.8.2.2.1. the animals have been subjected with positive results to a serological test carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]]
and/or [II.2.8.2.2.2. the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days prior to the date of the departure of the consignment and to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment.]]]]
and/or [II.2.8. They do not fulfil the requirements laid down in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of the Member State of origin authorised movement of those animals to another Member State or zone thereof:
either [II.2.8.1. with the status free from infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:
either [II.2.8.1.1. Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and
and/or [II.2.8.1.2. Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and
and/or [II.2.8.1.3. Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and
and/or [II.2.8.1.4. Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and
the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]
and/or [II.2.8.2. with an approved eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:
either [II.2.8.2.1. Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and
and/or [II.2.8.2.2. Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and
and/or [II.2.8.2.3. Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and
and/or [II.2.8.2.4. Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and
the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]]
and/or [II.2.8.3. neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised:
either [II.2.8.3.1. without any conditions, and
and/or [II.2.8.3.2. subject to the conditions referred to in Part II, Chapter 2, Section 1, point 5, of Annex V to Delegated Regulation (EU) 2020/689, and
and/or [II.2.8.3.3. subject to the conditions referred to in Part II, Chapter 2, Section 1, point 6, of Annex V to Delegated Regulation (EU) 2020/689, and